标题
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-01-28
DOI
10.3389/fimmu.2020.00018
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
- (2019) Gregor Hutter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer
- (2019) Aesha I. Ali et al. Frontiers in Oncology
- Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma
- (2019) Suchismita Mohanty et al. Cell Death & Disease
- CD47/SIRPα blocking enhances CD19/CD3-bispecific T cell engager antibody-mediated lysis of B cell malignancies
- (2019) Lijun Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
- (2019) Fangyuan Zhou et al. ADVANCED MATERIALS
- RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-α on Monocytes/Macrophages
- (2019) Pedro Cabrales Translational Oncology
- Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα
- (2019) Janet Sim et al. mAbs
- Programmable bacteria induce durable tumor regression and systemic antitumor immunity
- (2019) Sreyan Chowdhury et al. NATURE MEDICINE
- Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review
- (2018) Atlantis Russ et al. BLOOD REVIEWS
- Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma
- (2018) Xuyao Zhang et al. CARCINOGENESIS
- miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene
- (2018) Yongwen Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Chimeric antigen receptor T cell therapy in pancreatic cancer: from research to practice
- (2018) Vishal Jindal et al. MEDICAL ONCOLOGY
- MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
- (2018) Wei Huang et al. Molecular Cancer
- Preclinical development of a bispecific antibody that safely and effectively targets CD19 and CD47 for the treatment of B cell lymphoma and leukemia
- (2018) Vanessa Buatois et al. MOLECULAR CANCER THERAPEUTICS
- A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a “Glutamine Trap” To Inhibit Lung Cancer Cell Growth
- (2018) Jiamin Wu et al. MOLECULAR PHARMACEUTICS
- CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells
- (2018) Hiroyuki Abe et al. VIRCHOWS ARCHIV
- CD47-ligation induced cell death in T-acute lymphoblastic leukemia
- (2018) Pascal Leclair et al. Cell Death & Disease
- Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma
- (2018) Lei Wu et al. OncoImmunology
- Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects
- (2018) Lien De Beck et al. OncoImmunology
- Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy
- (2018) Yismeilin R. Feliz-Mosquea et al. BREAST CANCER RESEARCH AND TREATMENT
- The contribution of cross-talk between the cell-surface proteins CD36 and CD47–TSP-1 in osteoclast formation and function
- (2018) Srinivas V. Koduru et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 4Mu decreases CD47 expression on hepatic cancer stem cells and primes a potent antitumor T-cell response induced by interleukin-12
- (2018) Marcelo M. Rodríguez et al. MOLECULAR THERAPY
- ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile
- (2018) Steven E. Kauder et al. PLoS One
- CD 47 agonist peptide PKHB 1 induces immunogenic cell death in T‐cell acute lymphoblastic leukemia cells
- (2018) Ashanti Concepción Uscanga‐Palomeque et al. CANCER SCIENCE
- Inhibited CD47 gene affects the clearance of acute myelogenous leukemia stem cells
- (2018) Guangle Song et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression and significance of CD47, PD1 and PDL1 in T-cell acute lymphoblastic lymphoma/leukemia
- (2018) Kun Yang et al. PATHOLOGY RESEARCH AND PRACTICE
- A Raman Imaging Approach Using CD47 Antibody-Labeled SERS Nanoparticles for Identifying Breast Cancer and Its Potential to Guide Surgical Resection
- (2018) Ryan Davis et al. Nanomaterials
- Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
- (2018) Hanne Locy et al. Frontiers in Immunology
- Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis
- (2018) Kulthida Vaeteewoottacharn et al. Translational Oncology
- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
- (2017) Hanke L. Matlung et al. IMMUNOLOGICAL REVIEWS
- Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma
- (2017) Xu-Jie Liu et al. International Journal of Nanomedicine
- Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses
- (2017) Boning Liu et al. mAbs
- Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer
- (2017) Gashin Rezaei et al. Nanomedicine
- Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
- (2017) Nan Guo Ring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Significance of CD47 expression in gastric cancer
- (2017) Tomoya Sudo et al. Oncology Letters
- Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies
- (2017) E C Pietsch et al. Blood Cancer Journal
- SIRPα-antibody fusion proteins stimulate phagocytosis and promote elimination of acute myeloid leukemia cells
- (2017) Laia Pascual Ponce et al. Oncotarget
- Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
- (2017) Liang Liu et al. Frontiers in Immunology
- Blocking the CD47-SIRPα axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells
- (2017) Feng Li et al. OncoImmunology
- CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth
- (2017) Vita Golubovskaya et al. Cancers
- Fluorogenic 2D Peptidosheet Unravels CD47 as a Potential Biomarker for Profiling Hepatocellular Carcinoma and Cholangiocarcinoma Tissues
- (2016) Yun-Han Ma et al. ADVANCED MATERIALS
- Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment
- (2016) Liang Zhang et al. Anti-Cancer Agents in Medicinal Chemistry
- SIRP -Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells
- (2016) E. C. Piccione et al. CLINICAL CANCER RESEARCH
- TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
- (2016) Penka S. Petrova et al. CLINICAL CANCER RESEARCH
- The CD47 “don't eat me signal” is highly expressed in human ovarian cancer
- (2016) R.M. Brightwell et al. GYNECOLOGIC ONCOLOGY
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- Durable antitumor responses to CD47 blockade require adaptive immune stimulation
- (2016) Jonathan T. Sockolosky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A fully human anti-CD47 blocking antibody with therapeutic potential for cancer
- (2016) Dadi Zeng et al. Oncotarget
- Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
- (2016) K. Weiskopf et al. Cancer Immunology Research
- Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
- (2016) Michael Zhang et al. PLoS One
- CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
- (2016) Hui Zhao et al. Scientific Reports
- Expression of mouse CD47 on human cancer cells profoundly increases tumor metastasis in murine models
- (2015) Armando Rivera et al. BMC CANCER
- Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
- (2015) Zhenyu Xiao et al. CANCER LETTERS
- Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
- (2015) Chi-Ping Day et al. CELL
- Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 "Don't Eat Me" Signals
- (2015) M. N. McCracken et al. CLINICAL CANCER RESEARCH
- Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
- (2015) M. Cioffi et al. CLINICAL CANCER RESEARCH
- Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
- (2015) Huimin Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- “Velcro” Engineering of High Affinity CD47 Ectodomain as Signal Regulatory Protein α (SIRPα) Antagonists That Enhance Antibody-dependent Cellular Phagocytosis
- (2015) Chia Chi M. Ho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysis
- (2015) Serena Galli et al. LEUKEMIA RESEARCH
- Anti-CD47 antibody suppresses tumour growth and augments the effect of chemotherapy treatment in hepatocellular carcinoma
- (2015) Jessica Lo et al. LIVER INTERNATIONAL
- A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells
- (2015) Emily C Piccione et al. mAbs
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
- (2015) Ji-Feng Xu et al. Oncotarget
- miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47
- (2015) Seung Yeob Yang et al. Oncotarget
- CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans
- (2015) Ana-Carolina Martinez-Torres et al. PLOS MEDICINE
- CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
- (2015) Kazumichi Yoshida et al. Cancer Medicine
- Therapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer
- (2015) David D. Roberts et al. Journal of Cell Communication and Signaling
- Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
- (2015) Jie Liu et al. PLoS One
- CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
- (2014) D. R. Soto-Pantoja et al. CANCER RESEARCH
- Effect of CD74 on the prognosis of patients with resectable pancreatic cancer
- (2014) Jun-Feng Zhang et al. Hepatobiliary & Pancreatic Diseases International
- Studying the mechanism of CD47–SIRPα interactions on red blood cells by single molecule force spectroscopy
- (2014) Yangang Pan et al. Nanoscale
- On the dot—targeted molecular imaging
- (2014) Louise Stone Nature Reviews Urology
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration
- (2013) Yuan Zhang et al. EUROPEAN JOURNAL OF CANCER
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
- (2013) D. Tseng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- (2013) K. Weiskopf et al. SCIENCE
- CD47 functions as a molecular switch for erythrocyte phagocytosis
- (2012) P. Burger et al. BLOOD
- CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest
- (2012) E Sick et al. BRITISH JOURNAL OF PHARMACOLOGY
- The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications
- (2012) Mark P Chao et al. CURRENT OPINION IN IMMUNOLOGY
- Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
- (2012) D Kim et al. LEUKEMIA
- Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
- (2012) B. Edris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro
- (2012) Yan Lin et al. PROTEIN EXPRESSION AND PURIFICATION
- Role of CD47 and Signal Regulatory Protein Alpha (SIRPa) in Regulating the Clearance of Viable or Aged Blood Cells
- (2012) Per-Arne Oldenborg TRANSFUSION MEDICINE AND HEMOTHERAPY
- Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
- (2011) M. P. Chao et al. BLOOD
- Cdc42 in oncogenic transformation, invasion, and tumorigenesis
- (2011) Kristy Stengel et al. CELLULAR SIGNALLING
- The CD47 pathway is deregulated in human immune thrombocytopenia
- (2011) Lucia Catani et al. EXPERIMENTAL HEMATOLOGY
- CD47-signal regulatory protein- (SIRP ) interactions form a barrier for antibody-mediated tumor cell destruction
- (2011) X. W. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia
- (2010) Mark P. Chao et al. CANCER RESEARCH
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Correlated Expression of CD47 and SIRPA in Bone Marrow and in Peripheral Blood Predicts Recurrence in Breast Cancer Patients
- (2010) M. Nagahara et al. CLINICAL CANCER RESEARCH
- Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
- (2010) M. P. Chao et al. Science Translational Medicine
- Macrophages as mediators of tumor immunosurveillance
- (2010) Siddhartha Jaiswal et al. TRENDS IN IMMUNOLOGY
- Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease
- (2009) A. Kukreja et al. BLOOD
- CD47 Regulates Bone Mass and Tumor Metastasis to Bone
- (2009) O. Uluckan et al. CANCER RESEARCH
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Functions and molecular mechanisms of the CD47–SIRPα signalling pathway
- (2009) Takashi Matozaki et al. TRENDS IN CELL BIOLOGY
- Association of CD47 with Natural Killer Cell-Mediated Cytotoxicity of Head-and-Neck Squamous Cell Carcinoma Lines
- (2008) Min Jung Kim et al. TUMOR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started